About Neurogenic arthrogryposis multiplex congenita
Neurogenic arthrogryposis multiplex congenita is a rare disease catalogued by Orphanet (ORPHA:1143). It is associated with the SCYL2, COL25A1, ERGIC1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neurogenic arthrogryposis multiplex congenita trials.
Search ClinicalTrials.gov for "Neurogenic arthrogryposis multiplex congenita" or filter by Orphanet code ORPHA:1143 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neurogenic arthrogryposis multiplex congenita trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neurogenic arthrogryposis multiplex congenita. Updated daily.